USD 0.17
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -65.61 Thousand USD | 37.76% |
2022 | -105.41 Thousand USD | 18.96% |
2021 | -130.06 Thousand USD | -107.22% |
2020 | -62.77 Thousand USD | 28.74% |
2019 | -88.09 Thousand USD | -57.28% |
2018 | -56.01 Thousand USD | 15.24% |
2017 | -66.08 Thousand USD | 86.42% |
2016 | -486.45 Thousand USD | -23981.68% |
2015 | -2020.00 USD | 0.0% |
2013 | -18.16 Thousand USD | 0.0% |
2012 | - USD | 0.0% |
2007 | 562.07 Thousand USD | -19.67% |
2006 | 699.68 Thousand USD | -28.47% |
2005 | 978.14 Thousand USD | 85.73% |
2004 | 526.66 Thousand USD | 2.11% |
2003 | 515.79 Thousand USD | -77.39% |
2002 | 2.28 Million USD | 350.25% |
2001 | 506.72 Thousand USD | -96.17% |
2000 | 13.23 Million USD | 840426.1% |
1999 | 1575.00 USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 102.87 Thousand USD | 119.67% |
2023 Q2 | -57.92 Thousand USD | -365.59% |
2023 Q4 | 46.83 Thousand USD | 211.31% |
2023 Q1 | -12.44 Thousand USD | -21.37% |
2023 FY | -65.61 Thousand USD | 37.76% |
2023 Q3 | -42.07 Thousand USD | 27.37% |
2022 Q2 | -22.78 Thousand USD | 38.18% |
2022 Q1 | -36.85 Thousand USD | -14.19% |
2022 Q4 | -10.25 Thousand USD | 71.15% |
2022 FY | -105.41 Thousand USD | 18.96% |
2022 Q3 | -35.53 Thousand USD | -55.97% |
2021 FY | -130.06 Thousand USD | -107.22% |
2021 Q3 | -39.61 Thousand USD | -17.61% |
2021 Q2 | -33.68 Thousand USD | -37.47% |
2021 Q4 | -32.27 Thousand USD | 18.53% |
2021 Q1 | -24.5 Thousand USD | -81.21% |
2020 Q1 | -27.58 Thousand USD | -27.45% |
2020 Q3 | -11.87 Thousand USD | -21.25% |
2020 Q4 | -13.52 Thousand USD | -13.9% |
2020 FY | -62.77 Thousand USD | 28.74% |
2020 Q2 | -9790.00 USD | 64.5% |
2019 FY | -88.09 Thousand USD | -57.28% |
2019 Q1 | -28.33 Thousand USD | -59.88% |
2019 Q2 | -18.49 Thousand USD | 34.73% |
2019 Q4 | -21.64 Thousand USD | -10.24% |
2019 Q3 | -19.63 Thousand USD | -6.17% |
2018 Q1 | -3960.00 USD | 0.0% |
2018 Q2 | -6970.00 USD | -76.01% |
2018 Q4 | -17.72 Thousand USD | 35.21% |
2018 Q3 | -27.35 Thousand USD | -292.4% |
2018 FY | -56.01 Thousand USD | 15.24% |
2017 FY | -66.08 Thousand USD | 86.42% |
2016 FY | -486.45 Thousand USD | -23981.68% |
2015 FY | -2020.00 USD | 0.0% |
2013 FY | -18.16 Thousand USD | 0.0% |
2012 FY | - USD | 0.0% |
2008 Q1 | 107.13 Thousand USD | -12.16% |
2008 Q3 | 111.76 Thousand USD | -8.7% |
2008 Q2 | 122.4 Thousand USD | 14.26% |
2007 Q3 | 138.86 Thousand USD | -6.53% |
2007 Q4 | 121.96 Thousand USD | -12.17% |
2007 FY | 562.07 Thousand USD | -19.67% |
2007 Q1 | 152.66 Thousand USD | -48.46% |
2007 Q2 | 148.57 Thousand USD | -2.68% |
2006 Q3 | 106.29 Thousand USD | -21.37% |
2006 FY | 699.68 Thousand USD | -28.47% |
2006 Q4 | 296.21 Thousand USD | 178.67% |
2006 Q2 | 135.18 Thousand USD | -14.42% |
2006 Q1 | 157.95 Thousand USD | -1.28% |
2005 Q4 | 160.01 Thousand USD | -23.42% |
2005 FY | 978.14 Thousand USD | 85.73% |
2005 Q3 | 208.93 Thousand USD | -56.3% |
2005 Q2 | 478.09 Thousand USD | 264.67% |
2005 Q1 | 131.1 Thousand USD | -9.09% |
2004 Q1 | 118.36 Thousand USD | -18.01% |
2004 FY | 526.66 Thousand USD | 2.11% |
2004 Q2 | 134.44 Thousand USD | 13.59% |
2004 Q3 | 112.18 Thousand USD | -16.56% |
2004 Q4 | 144.21 Thousand USD | 28.55% |
2003 Q4 | 144.36 Thousand USD | -7.83% |
2003 Q3 | 156.62 Thousand USD | 37.11% |
2003 Q2 | 114.23 Thousand USD | 13.57% |
2003 Q1 | 100.58 Thousand USD | -81.9% |
2003 FY | 515.79 Thousand USD | -77.39% |
2002 Q4 | 555.76 Thousand USD | 1245.95% |
2002 FY | 2.28 Million USD | 350.25% |
2002 Q3 | 41.29 Thousand USD | -17.78% |
2002 Q2 | 50.22 Thousand USD | 0.0% |
2001 FY | 506.72 Thousand USD | -96.17% |
2000 FY | 13.23 Million USD | 840426.1% |
1999 FY | 1575.00 USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Achiko AG | -8.35 Million USD | 99.215% |
Accelera Innovations, Inc | - USD | Infinity% |
Aspyra Inc. | 4.7 Million USD | 101.395% |
Cannabis Sativa, Inc. | -855.85 Thousand USD | 92.334% |
CompuMed, Inc. | -31.2 Thousand USD | -110.275% |
CompuGroup Medical SE & Co. KGaA | 171.25 Million USD | 100.038% |
Cogstate Limited | 660.18 Thousand USD | 109.938% |
CareView Communications, Inc. | -688.3 Thousand USD | 90.468% |
Craneware plc | 19.73 Million USD | 100.332% |
Caduceus Software Systems Corp. | -1.15 Million USD | 94.316% |
Certive Solutions Inc. | -2.1 Million USD | 96.877% |
Drug Free Solution, Inc. | -1.4 Million USD | 95.338% |
DATATRAK International, Inc. | 1.87 Million USD | 103.492% |
Healixa Inc. | -6.35 Million USD | 98.967% |
Easy Technologies Inc. | - USD | Infinity% |
eWellness Healthcare Corporation | - USD | Infinity% |
Founders Bay Holdings | 9.02 Million USD | 100.727% |
Health Discovery Corporation | - USD | Infinity% |
Healthcare Integrated Technologies, Inc. | -983.56 Thousand USD | 93.329% |
H-Source Holdings Ltd. | - USD | Infinity% |
InterCare DX, Inc. | -789.33 USD | -8212.113% |
IQ-AI Limited | -517.25 Thousand USD | 87.316% |
Cannabiz Mobile, Inc. | -750.00 USD | -8648.0% |
Mednow Inc. | -17.04 Million USD | 99.615% |
Galileo Life Sciences, Inc. | -271.37 Thousand USD | 75.823% |
MediXall Group, Inc. | -6.54 Million USD | 98.997% |
Mitesco, Inc. | -2.58 Million USD | 97.464% |
MobileSmith, Inc. | -7.81 Million USD | 99.161% |
NantHealth, Inc. | -51.32 Million USD | 99.872% |
Net Medical Xpress Solutions, Inc. | -1.82 Million USD | 96.397% |
OneLife Technologies Corp. | - USD | Infinity% |
ORHub, Inc. | -12.15 Million USD | 99.46% |
Patient Access Solutions, Inc. | -9 Million USD | 99.271% |
Pharma-Bio Serv, Inc. | 1.11 Million USD | 105.872% |
PPJ Healthcare Enterprises, Inc. | 74.72 Thousand USD | 187.798% |
Medical Cannabis Payment Solutions, Inc. | -34.1 Thousand USD | -92.405% |
Renalytix Plc | -29.6 Million USD | 99.778% |
Revium Recovery Inc. | -679 Thousand USD | 90.337% |
RYAH Group, Inc. | - USD | Infinity% |
Carepay Inc. | 396.65 Thousand USD | 116.541% |
Vaso Corporation | 4.19 Million USD | 101.564% |
Vynleads, Inc. | -235.73 Thousand USD | 72.167% |